Navigation Links
Hill-Rom Innovative TotalCare(R) Bariatric Plus Therapy System Receives Gold Medical Device Excellence Award
Date:6/5/2008

nd engineering features, including innovative use of materials, user-related functions that improve health care delivery and change traditional medical attitudes or practices, features that provide enhanced benefits to the patient, and the ability of the product development team to overcome design and engineering challenges so that the product meets its clinical objectives. A comprehensive review of the entries was performed by an impartial, multidisciplinary panel of third-party jurors with expertise in biomedical engineering, human factors, industrial design, medicine and diagnostics.

According to one of the judges, "This modern-looking bed meets a critical need in the patient-care world -- accommodating large individuals who do not fit in conventionally sized hospital beds." He added that, "clearly, designing such a bed takes a keen knowledge of bariatric patients."*

Key to the innovative quality of the bed are features that enhance microclimate management, including the ability to wick heat and moisture underneath the patient to the head of the mattress and then expel them into the atmosphere. Elements of the surface adjust to individual patients to optimize interface pressure.

The 2008 Medical Design Excellence Award winners were announced and honored at a June 4 ceremony during the Medical Design & Manufacturing (MD&M) East Conference and Exposition June 3-5, 2008 in New York.

Last year Hill-Rom received the Gold 2007 Medical Device Excellence Award for The Vest(R) Airway Clearance System, Model 205. The Vest System is a device to help patients with respiratory conditions clear airway secretions.

*Note: As cited in MD&DI, April 2008, page 50.

ABOUT HILL-ROM

Hill-Rom is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, non-invasive therapeutic products for a variety of acute and chronic medical conditions, me
'/>"/>

SOURCE Hill-Rom
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill-Rom 10th Annual Pressure Ulcer Survey
2. Hill-Rom Announces Singapore Will Be Site for Asia-Pacific Innovation Center
3. Hill-Rom Introduces Fashionable, Affordable Bed for Home and Post-Acute Care Patients
4. Cerner Corporation and Hill-Rom Partner to Unify Hospital Care Delivery
5. Hill-Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill-Rom Products Using Nanotechnology
6. Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill-Rom and Batesville Casket
7. Hill-Rom Holdings, Inc. Announces Completion of Separation of Hillenbrand Industries Creating Two Public Companies
8. Hill-Roms NaviCare(R) WatchChild(R) Solution Provides Enhanced Information Technology Solutions for Obstetrical Care
9. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2008 Second Quarter Earnings Webcast
10. Hill-Rom to Present at the Bank of America 2008 Health Care Conference
11. Hill-Rom to Present at the Citi Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... , Pioneering Neurologist Closer to Understand...v. 20 Dr. Jeremy Schmah...hool and neurologist at the Massachusetts General ...ented his laboratory,s research on the new field o... MINDlink Foundation. ,, Dr. Schmahmann is an a...
(Date:11/20/2009)... , QUINCY, Mass., Nov. 20 Foll...ermarket Company removed from sale Shedd,s Country...Rice and Shedd,s Country Crock ® Side Dishes ...ite allergen. ,, The following code dates and ...174; Side Dishes DELUXE Cheddar Broccoli Rice 21 o...
(Date:11/20/2009)... , ST. LOUIS, Nov. 20 /PRNewswire-FirstCall...nounced that it will present at the Bank of Americ... December 2-3, 2009, at the Crowne Plaza Hotel Tim...sent Wednesday, December 2nd at 8:30 a.m. Eastern ...ccess a live, audio webcast of Centene,s presentat...
(Date:11/20/2009)... , NEW YORK, Nov. 20 /PRNewswire-FirstCal...ounced that it will broadcast Doctor Radio Repo...ms , an in-depth special hosted by veteran journal....com/cgi-bin/prnh/20080819/NYTU044LOGO ) ,, Do...ow About Mammograms will air November 21 live a...
(Date:11/20/2009)...eattle, Washington) November 20, 2009Emergency med...assess an estimated 350,000 cardiac arrests each y...en cardiac arrest survive. Better quality cardiop...al EMS providers may be associated with better pat...um (ROC) is the largest clinical research network ...
Breaking Medicine News(10 mins):Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3
...orm womb transplantation on human patients. //This...human primate, a rhesus monkey, last month by a te... The review board at New York Downtown Hospital...e. Women undergoing the transplant would be gi...
... parts of diptheria toxin as a way to prompt the i...cell of patients suffering from advanced melanoma ...clinical trial to test the drug denileukin diftito...tion of both tumours and metastases. The two other...
...ns as an important additional tool in doctors' med... remote areas. // AMA President, Dr Mukesh Ha...acknowledging the potential advantages that techno...onsultations, the AMA's Federal Council made it cl...
...activity from the Health Research Board (HRB) has ...ychiatric units and hospitals //continued to fall ...04 to 21,253 admissions in 2005, demonstrating a d...ons and 12% of first admissions. 21,265 discharges...
...aunched to give online support to people with ment...t 'Our Choices in Mental Health', the new national...tments at a local level. // The Department o...s drafted in consultation with users and people co...
...o bladder cancer later in life, says a new study. ...er British researchers analysed data of about 430,...o smoked before the age of 15 were three times mor...etween smoking and bladder cancer - a disease that...
Other Medicine News:Health News:Human Uterine Transplant In Near Future 2Health News:Diptheria Toxin And Interleukin2 Help Killing Melanoma Tumour Cells 2Health News:E-Consultations Given Go-Ahead 2Health News:New Website For People With Mental Problems 2
(Date:11/20/2009)...IS, Nov. 20 Biotel Inc. ...ts first quarter ended September 30, 2009 with net... on revenues of $3,263,000. This compares to net ...on revenues of $3,168,000 for the first quarter of...results, Biotel President and CEO Steve Springrose...
(Date:11/20/2009)...TON, N.J., Nov. 20 Solig...r the Company), formerly known as DOR BioPharma, I... today that it has formed a consortium to develop ...ther rapidly acting vaccines. Soligenix received a... Allergy and Infectious Diseases (NIAID), a divisi...
(Date:11/19/2009)...INAN, Taiwan, Nov. 19 /PRNewswire-Asia/ -- ScinoPh...tical ingredients (APIs), announced that its,Taina... Certification from,SafeBridge(R) Consultants, Inc...cy and proficiency in the safe handling of potent ...ies to specific laboratories and,production areas ...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2The Welcome Back Awards Seeks Nominations to Recognize Those Dedicated to the Depression Community 58258 1The Welcome Back Awards Seeks Nominations to Recognize Those Dedicated to the Depression Community 58258 2The Welcome Back Awards Seeks Nominations to Recognize Those Dedicated to the Depression Community 58258 3Rapid Fire Marketing Signs 5 Year Agreement 58256 1Rapid Fire Marketing Signs 5 Year Agreement 58256 2NCQA and Lilly Launch Online Quality Improvement Guide to Help Reduce Health Care Disparities and Improve Patient Care 58254 1NCQA and Lilly Launch Online Quality Improvement Guide to Help Reduce Health Care Disparities and Improve Patient Care 58254 2NCQA and Lilly Launch Online Quality Improvement Guide to Help Reduce Health Care Disparities and Improve Patient Care 58254 3NCQA and Lilly Launch Online Quality Improvement Guide to Help Reduce Health Care Disparities and Improve Patient Care 58254 4
...Pain Relief with the 2.5 and 5 m...., March 3 Alexza,Pharmaceuticals, Inc. (Nasdaq: ...from its 168 patient Phase 2a clinical trial of AZ...ine headache. Migraine is a debilitating,yet commo...f severe,headache and autonomic nervous system dys...
...of,North America, a wholly-owned subsidiary of Tok...Food and Drug Administration (FDA) has accepted an...for the short-term (up to,eight weeks) treatment o...ts ages 12-16. Further, FDA has indicated that the...ith the Best Pharmaceuticals for Children,Act, whi...
Other Medicine Technology:Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 2Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 3Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 4Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 5Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 6Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 7Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 8FDA Grants Priority Review for ACIPHEX(R) (rabeprazole sodium) sNDA for Short-Term Treatment of GERD in Adolescents 2
Full Handle Laseredge Implant Blade Knife, 3.5 mm round tip
Full Handle Laseredge Crescent Blade Knife, angled bevel down
Full Handle Laseredge Stab Blade Knife, 45 blade
Disposable Bipolar Pencil - 23 Gauge Tapered Tip
Medicine Products: